Femtosecond LASIK with Corneal Cross-Linking (FS-LASIK Xtra) for Myopic Astigmatism in Eyes with Asymmetric Cornea: A Retrospective Comparative Study of UVA Energy Protocols
This retrospective study of 114 eyes with myopic astigmatism and asymmetric corneas found that combining femtosecond LASIK with corneal cross-linking using either 3.6 J/cm² or 2.7 J/cm² UVA energy protocols yielded excellent, safe, and stable visual and refractive outcomes over 12 months, with no statistically significant differences between the two energy levels.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
The human eye is a marvel of optical engineering, relying on a clear, dome-shaped window at the front called the cornea to focus light onto the retina. For millions of people, this window is shaped incorrectly, bending light too sharply and causing nearsightedness or astigmatism. To fix this, surgeons have long used lasers to gently reshape the cornea, a procedure known as LASIK. However, this reshaping process removes a tiny amount of tissue, which can subtly weaken the structural integrity of the eye's front surface. In some individuals, particularly those with naturally thinner corneas or irregular shapes, this weakening can lead to a serious complication where the cornea begins to bulge outward over time, distorting vision permanently. To prevent this, doctors have developed a safety technique that strengthens the cornea's internal fibers, much like reinforcing a bridge with steel cables, ensuring it remains stable even after the laser has done its work.
A team of researchers in China recently set out to test how well this combined approach works for a specific group of patients: those whose corneas are naturally uneven or asymmetric. These irregular shapes make the eye more vulnerable to the weakening effects of laser surgery. The study focused on comparing two different methods of applying the strengthening treatment. The researchers wanted to know if using a higher dose of ultraviolet light to activate the strengthening solution would yield better results than the standard, lower dose. They followed 114 patients who underwent this combined surgery, tracking their vision and the physical shape of their eyes over a full year to see if the higher energy offered any real advantage or if the standard method was sufficient.
The study took place at a specialized eye hospital in Beijing, where surgeons treated 114 patients suffering from myopic astigmatism and asymmetric corneas. The patients were divided into two groups based on the amount of ultraviolet-A energy used during the strengthening phase of the surgery. One group received a total energy dose of 3.6 joules per square centimeter, while the other group received a lower dose of 2.7 joules per square centimeter. The surgical process itself was identical for everyone: a femtosecond laser created a thin flap on the surface of the eye, an excimer laser reshaped the underlying tissue to correct the vision, and a riboflavin solution was applied to the exposed area. The eye was then exposed to ultraviolet light to trigger a chemical reaction that bonds the collagen fibers together, hardening the cornea. The only variable was the duration of the light exposure, which determined the total energy delivered.
Over the course of twelve months, the researchers measured how well the patients could see without glasses, how accurate their vision was, and whether the shape of their corneas remained stable. The results were encouraging for both groups. By the end of the year, nearly all patients in both groups achieved excellent vision, with almost everyone seeing clearly enough to pass a standard driver's license test without correction. The vast majority of patients also ended up with the exact amount of vision correction the surgeons had planned. When the researchers looked closely at the data, they found that the group receiving the higher energy dose showed a tiny, almost imperceptible edge in stability, with their corneal curves and vision remaining slightly more consistent over time. However, this difference was so small that it did not reach the level of statistical significance, meaning it could not be definitively proven that the higher dose was superior.
Safety was a primary concern, and the study confirmed that the procedure was well-tolerated. A small number of patients in both groups developed a mild, temporary clouding of the cornea shortly after surgery, but this cleared up completely with standard steroid eye drops. Crucially, no cases of the feared corneal bulging, known as ectasia, occurred in either group. The thickness of the cornea changed slightly as expected after the laser treatment, but it stabilized quickly, and the cells lining the back of the eye remained healthy and unchanged. The researchers noted that the patients with the higher energy dose did experience a slightly more pronounced thickening of the cornea in the months following surgery, which suggests the tissue was reacting to the treatment, but this did not lead to any negative outcomes.
Ultimately, the study concludes that both energy protocols are safe and effective for correcting vision in eyes with irregular shapes. While the higher energy dose of 3.6 joules per square centimeter showed a hint of better stability in the data, the difference was not large enough to declare it the clear winner over the standard 2.7 joules per square centimeter dose. The findings suggest that surgeons have flexibility in choosing their approach, as both methods successfully protect the eye from weakening while delivering sharp, clear vision. The researchers emphasized that because this was a study of a relatively small number of patients followed for one year, further long-term studies with larger groups are needed to confirm these results and determine if the higher energy offers benefits that only appear after many years. For now, the combined surgery stands as a reliable option for patients with complex corneal shapes, offering a way to correct vision while actively guarding against future structural problems.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.